Therapeutic Areas: Dermatology | Oncology | Family Medicine

Melanoma Clinical Trials


A listing of Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Birmingham : University of Alabama Comprehensive Cancer Center SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mobile : Southern Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Mobile : University of South Alabama / Mitchell Cancer Institute SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Arizona

Chandler : Ironwood Cancer & Research Centers

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gilbert : Banner MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Goodyear : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Phoenix : Phoenix Children'S Hospital Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Phoenix : Arizona Oncology Associates SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Scottsdale : Pinnacle Oncology Hematology

A clinical trial to evaluate treatments using LY3009120 capsule for patients With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Scottsdale : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Scottsdale : Scottsdale Healthcare Research Institute

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tucson : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Tucson : The University of Arizona Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Tucson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tucson : University of Arizona Cancer Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Arkansas

Fayetteville : Highlands Oncology Group

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Fayetteville : Highlands Oncology Group SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fayetteville : Highlands Oncology Group SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fayetteville : Highlands Oncology Group Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Hot Springs : Genesis Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Hot Springs : Burke Pharmaceutical Research Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Little Rock : University of Arkansas for Medical Sciences Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

California

Beverly Hills : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Beverly Hills : Beverly Hills Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Duarte : Teva Investigational Site 10672

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Duarte : City of Hope Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Encinitas : California Cancer Associates for Research Excellence (cCARE)

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

La Jolla : UC San Diego

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

La Jolla : Scripps Clinic

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Loma Linda : Loma Linda University

A clinical research study of PEG-BCT-100 for the treatment of Hepatocellular Carcinoma, Renal Cell Carcinoma, Melanoma or Prostate Adenocarcinoma

Long Beach : Pacific Shores Medical Group

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Los Angeles : Childrens Hospital Of La Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Los Angeles : Jonsson Comprehensive Cancer Center

A clinical research study of sargramostim, sentinel lymph node biopsy, laboratory biomarker analysis and hypertonic saline for the treatment of Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma or Stage IIC Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : UCLA Medical Hematology & Oncology Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Los Angeles : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Los Angeles : UCLA Hematology-Oncology Clinic Updated

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles : The Angeles Clinic

A Phase 1 clinical study for patients with Malignant Melanoma

Los Angeles : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Los Angeles : Call for Information (Investigational Site 0001)

A Phase 1/Phase 2 clinical study for patients with Melanoma

Los Angeles : Call for Information (Investigational Site 0003)

A Phase 1/Phase 2 clinical study for patients with Melanoma

Los Angeles : USC/Kenneth Norris Comprehensive Cancer Center

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Los Angeles : Cedars Sinai Medical Center Cedars Sinai 4

A Phase 4 clinical study for patients using Pasireotide

Los Angeles : University of California Los Angeles

Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma

Los Angeles : The Angeles Clinic and Research Institute

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

Los Angeles :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : UCLA Hematology-Oncology Clinic Updated

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Los Angeles : Call for Information (Investigational Site 0001)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Los Angeles :

Patients are needed to participate in a clinical research study of Nivolumab + INCB24360

Los Angeles : UCLA

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Los Angeles : The Angeles Clinic and Research Institute

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Los Angeles : The Angeles Clinic and Research Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Los Angeles : The Angeles Clinic and Research Institute Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Newport Beach : Hoag Hospital

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

Orange : Children'S Hospital Of Orange County Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Orange : Chao Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma or Malignant Melanoma

Orange : Chao Family Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating Pazopanib and Paclitaxel for the treatment of Stage III Melanoma, Stage IV Melanoma or Unresectable Melanoma

Orange : University of California Irvine Irvine Medical Center

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oxnard : Ventura County Hematology Oncology Specialists Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

San Francisco : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

San Francisco : University of California, San Francisco

A clinical trial to evaluate treatments using BKM120 Combined with Vemurafenib (PLX4032) for patients with BRAF Mutant Metastatic Melanoma

San Francisco : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

San Francisco : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

San Francisco : California Pacific Medical Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

San Francisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Francisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Francisco : Northern California Melanoma Center/St. Mary's Medical Center

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

San Francisco : UCSF Helen Diller Comprehensive Cancer Center Updated

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

San Francisco : Northern California Melanoma Center/ St. Mary's Medical Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Santa Monica : Sarcoma Oncology Center

A clinical trial seeking patients for a research study for the treatment of Sarcoma, Melanoma, Non-small Cell Lung Cancer or Ovarian Cancer

Santa Monica : John Wayne Cancer Institute

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Santa monica : The Angeles & Clinic Research Institute

Patients are needed to participate in a clinical research study evaluating Ipilimumab and Nivolumab for the treatment of Melanoma

Santa Rosa : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Stanford : Stanford University Medical Center SC - 3

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Stanford : Stanford University Medical Center Stanford Hospital & Clinics

A Phase 4 clinical study for patients using Pasireotide

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Temecula : Advanced Dermatology and Skin Cancer Specialists Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Colorado

Aurora : Children'S Hospital Colorado Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Aurora : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Aurora :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Aurora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Aurora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Aurora : Anschutz Cancer Pavilion Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Denver : Sarah Cannon Research Institute at HealthONE Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Denver : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Englewood : AboutSkin Dermatology and DermSurgery

A clinical study for patients with Melanoma

Greenwood Village : Rocky Mountain Cancer Centers Dept of Rocky Mountain (2)

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Connecticut

New Haven : Smilow Cancer Hospital at Yale New Haven

A clinical trial to evaluate treatments using Vemurafenib for patients with Melanoma [C04.557.465.625.650.510]

New Haven : Yale Cancer Center

A Phase 1 clinical study for patients with Malignant Melanoma

New Haven : Yale School of Medicine

Patients are needed to participate in a clinical research study evaluating NY-ESO-1 for the treatment of Melanoma

New Haven : Yale University

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Delaware

Newark : Christiana Hospital Helen F. Graham Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

District of Columbia

Washington : Georgetown University

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Washington : Georgetown Lombardi Comprehsnive Cancer Center

A Phase 2 clinical study for patients with Melanoma

Washington : Georgetown University/Lombardi Cancer Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Washington : Washington Cancer Institute at MedStar Washington Hospital Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Georgetown Lombardi Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Call for Information (Investigational Site 0003)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Washington : Washington Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Washington : The Melanoma Center at the Washington Cancer Institute Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Florida

Boca Raton : Skin Care Research, Inc. Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Boynton Beach : University Cancer Institute SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fort Myers : Teva Investigational Site 10673

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Fort Myers : Florida Cancer Specialists SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fort Myers : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Fort Myers : Florida Cancer Specialists

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

Jacksonville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Jacksonville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Jacksonville : Cancer Specialists of North Florida

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Jacksonville : Cancer Specialists of North Florida Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Lake Worth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lakeland : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Miami : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Miami : University of Miami SC-3

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Miami Beach : MSMC Research Program

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Miami Beach : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Miami Beach : Mount Sinai Medical Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Miami Beach : Mount Sinai Medical Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Orlando : Clinical Site

A clinical trial to evaluate treatments using HF10 plus Ipilimumab for patients with Malignant Melanoma

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Orlando : MD Anderson Cancer Center-Orlando Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Ormond Beach : Ameriderm Research Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Sarasota : Florida Cancer Specialists & Research Institute Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Sarasota :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Tallahassee : Dermatology Associates of Tallahassee

A clinical study for patients with Melanoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Tampa : Moffitt Cancer Center Updated

A clinical trial to evaluate treatments using MGA271 for patients

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A Phase 1 clinical study for patients with Melanoma (Skin)

Tampa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study evaluating Panobinostat and Ipilimumab for the treatment of Melanoma or Skin Cancer

Tampa : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Tampa : Moffitt Cancer Center Updated

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of XL888 and Vemurafenib to evaluate Melanoma

West Palm Beach : Florida Cancer Specialists

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

Georgia

Savannah : Memorial University Medical Center

CTSU/ECOG E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High-Risk Melanoma

Atlanta : Georgia Cancer Specialists/Northside Hospital Cancer Institute

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Atlanta : Emory University/Winship Cancer Institute

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Augusta :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Augusta : Georgia Regents University

A Phase 1/Phase 2 clinical study for patients with Metastatic Melanoma, Stage III Melanoma or Stage IV Melanoma

Augusta : Georgia Regents University

Patients are needed to participate in a clinical research study of NLG919 to evaluate Solid Tumors, Breast Cancer, Lung Cancer or Pancreatic Cancer

Illinois

Elgin : Advocate Sherman Hospital

ECOG E1609 Phase III Randomized Study of Adjuvant Ipilimumab Versus High-Dose Recombinant Interferon Alfa-2b in Patients With High-Risk Stage IIIB, IIIC, or IV Melanoma

Chicago : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Chicago : The University of Chicago Updated

A clinical trial to evaluate treatments using MGA271 for patients

Chicago : Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Patients are needed to participate in a clinical research study of ALS-357 to evaluate Melanoma

Chicago : University of Illinois at Chicago SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Chicago : The University of Chicago Updated

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Chicago : University of Illinois at Chicago

Patients are needed to participate in a clinical research study of PAC-1

Niles : Oncology Specialists, S.C

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Niles : Oncology Specialists, SC (OSSC) Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Park Ridge : Oncology Specialists, SC

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC SC - 5

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Park Ridge : Oncology Specialists, SC SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Indiana

Goshen : Indiana University Health Goshen Center for Cancer SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Goshen : Indiana University Health Goshen Center for Cancer SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Indianapolis : James Whitcomb Riley Hospital For Children Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Indianapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Indianapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Indianapolis :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Indianapolis : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Indianapolis : Investigative Clinical Research of Indiana Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Iowa

Iowa City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Iowa City : University of Iowa Hospitals & Clinics

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Iowa City : University of Iowa Hospital and Clinics

A Phase 1/Phase 2 clinical study for patients with Metastatic Melanoma, Stage III Melanoma or Stage IV Melanoma

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating Temozolomide, Decitabine, Panobinostat for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

Patients are needed to participate in a clinical research study evaluating Vemurafenib, Decitabine for the treatment of Metastatic Melanoma, Melanoma, BRAF-mutated Metastatic Melanoma or V600EBRAF-mutated Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Sioux City : Siouxland Hematology-Oncology Associates LLP SHO

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kansas

Wichita : Cancer Center of Kansas

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kentucky

Lexington : Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation

A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAFV600E/K Mutant Melanoma

Lexington : University of Kentucky

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

Lexington : Central Baptist Hospital Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Louisville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Louisville : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Louisville : James Graham Brown Cancer Center

Patients are needed to participate in a clinical research study of A-dmDT390-bisFv(UCHT1) and Ionizing Radiation to evaluate Melanoma

Louisiana

Lake Charles : Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Metairie : Crescent City Research Consortium, LLC SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

New Orleans : Crescent City Research

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

New Orleans : Tulane University

Patients are needed to participate in a clinical research study evaluating 4-Demethyl-4-cholestryloxycarbonylpenclomedine for the treatment of Primary Brain Tumors or Secondary Brain Tumors

Maine

Bangor : Eastern Maine Medical Center Research Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Maryland

Baltimore : The Johns Hopkins University

A clinical study for patients with Melanoma

Baltimore : Weinberg Cancer Institute at Franklin Square Hospital Dept of Oncology

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Baltimore : Harry and Jeannette Weinberg Cancer Institute at Franklin Square

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Lutherville : Johns Hopkins Medicine

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Lutherville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Massachusetts

Boston : Massachusetts General Hospital

A clinical study for patients with Melanoma

Boston : Dana-Farber Cancer Institute Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Boston : Dana-Farber Cancer Institute

A clinical research study of STA-9090 for the treatment of Ocular Melanoma

Boston : Massachusetts General Hospital

A clinical research study of STA-9090 for the treatment of Ocular Melanoma

Boston : Dana Farber Cancer Institute Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Boston : Massachusetts General Hospital

A clinical trial to evaluate treatments using LY3009120 capsule for patients With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Boston : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Boston : Massachusetts General Hospital Cancer Center Updated

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Dana Farber Cancer Institute Updated

A clinical trial to evaluate treatments using MGA271 for patients

Boston : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Boston : Call for Information (Investigational Site 0002)

A Phase 1/Phase 2 clinical study for patients with Melanoma

Boston : Call for Information (Investigational Site 0005)

A Phase 1/Phase 2 clinical study for patients with Melanoma

Boston : Massachusetts General Hospital

A Phase 2 clinical study for patients with Melanoma

Boston : Massachusetts General Hospital SC -6

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Boston :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Tremelimumab and MEDI3617 for the treatment of Metastatic Melanoma

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Beth Israel Deaconess Medical Center (BIDMC)

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Research Site

Patients are needed to participate in a clinical research study of AMG 232, Trametinib and Dabrafenib

Boston : Dana Farber Harvard Cancer Center

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Boston : Massachusetts General Hospital SC -6

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Boston : Massachusetts General Hospital Cancer Center Updated

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Boston : Call for Information (Investigational Site 0004)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Boston : Call for Information (Investigational Site 0009)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Boston : Call for Information (Investigational Site 0010)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Rockland : Please Contact U.S. Medical Information

A clinical trial seeking patients for a research study for the treatment of Melanoma

Rockland : For Recruiting Locations in the United States, please Contact U.S. Medical Information Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Michigan

Ann Arbor : University of Michigan Comprehensive Cancer Center SC-2

A Phase 4 clinical study for patients using Pasireotide

Ann Arbor : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Detroit : Wayne State University/Karmanos Cancer Institute SC - 1

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grand Rapids : Mercy Health Saint Mary's SC-2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Grand Rapids : Mercy Health Saint Mary's Ofc of Research & Innovation

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Minnesota

Minneapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Minneapolis : Minnesota Oncology Hematology, P.A. Fridley Location

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Minneapolis : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Minneapolis : University of Minnesota Masonic Cancer Institute Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Rochester : Mayo Clinic Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Rochester : Mayo Clinic - Rochester Onc Dept

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Rochester : Mayo Clinic Cancer Center, Mayo Clinic Rochester Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Mississippi

Hattiesburg : Hattiesburgh Medical Oncology & Hematology

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hattiesburg : Forest General Hospital

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Jackson : Jackson Oncology Associates

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Missouri

Kansas City : Center for Pharmaceutical Research Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Manchester : Mercy Medical Research Institute SC-1

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

St. Joseph : MediSearch Clinical Trials Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

St. Louis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

St. Louis : Teva Investigational Site 10671

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

St. Louis : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

St. Louis : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

St. Louis : Saint Louis University Hospital

Patients are needed to participate in a clinical research study evaluating Fosaprepitant for the treatment of Chemotherapy-induced Nausea and Vomiting

St. Louis : Washington University in St. Louis

Patients are needed to participate in a clinical research study evaluating NY-ESO-1 for the treatment of Melanoma

St. Louis : St. Louis Hospital Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

St. Louis : Washington University School of Medicine Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Nebraska

Lincoln : Southeast Nebraska Oncology Cancer Center

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lincoln : Southeast Nebraska Hematology & Oncology Consultants

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Omaha : Nebraska Cancer Specialists, Midwest Cancer Center - Legacy

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Omaha : Nebraska Methodist Hospital Estabrook Cancer Center

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Omaha : Nebraska Methodist Hospital Nebraska Meth Hosp

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nevada

Las Vegas : Comprehensive Cancer Centers of Nevada CCC of Nevada (1)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Las Vegas : Comprehensive Cancer Centers of Nevada

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

New Jersey

Basking Ridge : Memorial Sloan Kettering Cancer Center at Basking Ridge Updated

A clinical research study of LGX818 for the treatment of Melanoma

Brick : Meridian Health Systems

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Camden : Cooper Cancer Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Hackensack : John Theurer Cancer Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Morristown : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Morristown : Atlantic Health, Atlantic Melanoma Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

New Brunswick : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

New Brunswick : Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School

Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melanoma Treated on Clinical Trial NCI-06-C-0200

New Brunswick : Cancer Center of NJ Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Verona : The Dermatology Group, P.C.

A clinical study for patients with Melanoma

New York

Bronx : Montefiore Medical Center SC-5

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Commack : Memorial Sloan Kettering Cancer Center at Commack Updated

A clinical research study of LGX818 for the treatment of Melanoma

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical research study of LGX818 for the treatment of Melanoma

New York : Melanoma and Sarcoma Service / Memorial Sloan Kettering Cancer Center

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

New York : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Dabrafenib for patients with Melanoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

New York : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

New York : Memorial Slone Kettering Cancer Center

A Phase 1 clinical study for patients with Malignant Melanoma

New York :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

New York : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

New York : Columbia University Medical Center

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : New York University School of Medicine

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Melphalan and Dactinomycin for the treatment of Melanoma

New York : NYU Clinical Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : NYU Langone Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : Icahn School of Medicine at Mount Sinai

Patients are needed to participate in a clinical research study of Vemurafenib to evaluate Melanoma

Rochester : University of Rochester MC / James P. Wilmot Cancer Center Rochester M.C. JP Wimot C Ctr.

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Rockville Centre : Memorial Sloan Kettering Cancer Center at Mercy Medical Center Updated

A clinical research study of LGX818 for the treatment of Melanoma

Sleepy Hollow : Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Updated

A clinical research study of LGX818 for the treatment of Melanoma

Troy : New York Oncology Hematology, P.C. NYOH Hematology Division

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

North Carolina

Chapel Hill : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina

A Phase 2 clinical study for patients with Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma or BRAF Mutant Melanoma

Chapel Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Durham : Duke University Health System

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Durham : Duke Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Huntersville : Carolina Biooncology Institute Updated

A clinical trial to evaluate treatments using MGA271 for patients

Huntersville : Carolina BioOncology Institute Updated

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Winston-Salem : Wake Forest Baptist Health

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Winston-Salem : Wake Forest School of Medicine

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Winston-Salem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Winston-Salem : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Winston-Salem : Wake Forest University School of Medicine, Comprehensive Cancer Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

North Dakota

Fargo : Sanford Research/USD-Fargo

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ohio

Canton : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Canton : Gabrail Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cincinnati : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Cincinnati : University of Cincinnati

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Cincinnati : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Cleveland : University Hospitals Case Medical Center

A clinical study for patients with Melanoma

Cleveland : Taussig Cancer Institute / Cleveland Clinic Foundation

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Cleveland : Siedman Cancer Center / University Hospitals of Cleveland

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Columbus : The Ohio State University Comprehensive Cancer Center

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Columbus : Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State University

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Columbus : Ohio State University

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Whole-Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery (SRS) for the treatment of Recurrent Melanoma, Stage IV Melanoma or Tumors Metastatic to Brain

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Patients are needed to participate in a clinical research study of selinexor and Correlative studies to evaluate Recurrent Melanoma

Columbus : Mid Ohio Oncology/Hematology, Inc., dba, The Mark H. Zangmeister Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Patients with Metastatic Melanoma are needed to participate in a clinical research study evaluating ipilimumab, stereotactic radiosurgery and laboratory biomarker analysis

Oklahoma

Oklahoma City : Stephenson Cancer Center at Oklahoma University TSET Phase 1 Program Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Oklahoma City : University of Oklahoma Health Sciences Center Univ OK HSC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tulsa : Tulsa Cancer Institute SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oregon

Bend : Bend Medical Clinic Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Portland : Oregon Health & Science University Onc. Dept

A clinical research study for the treatment of Melanoma

Portland : Providence Cancer Center

A clinical research study of CAVATAK (Coxsackievirus A21, CVA21) for the treatment of Malignant Melanoma

Portland : Providence Portland Medical Center

A clinical research study of CAVATAK and Ipilimumab for the treatment of Melanoma

Portland : Providence Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Portland : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Portland : Providence Portland Medical Center

A Phase 1 clinical study for patients with Metastatic Melanoma

Portland : Providence Health & Services

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Portland : Oregon Health & Science University SC-7

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Northwest Cancer Specialists Compass Oncology - SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Kaiser Permanente Northwest Dept of Kaiser Northwest (3)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Portland : Providence Portland Medical Center

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Portland : Providence Portland Medical Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Portland : Providence Portland Medical Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Pennsylvania

Bethlehem : St Luke's University Hospital and Health Network

A clinical trial seeking patients for a research study for the treatment of Melanoma

Bethlehem : Clinical Site

A clinical trial to evaluate treatments using HF10 plus Ipilimumab for patients with Malignant Melanoma

Bethlehem :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Bethlehem : St. Luke's Hospital and Health Network SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bethlehem : St. Luke's Hospital and Health Network SC-3

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bethlehem : St. Luke's University Health Network Updated

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Bethlehem : St. Luke's Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Easton : St.luke'S Hospital & Health Network

Patients are needed to participate in a clinical research study evaluating Ipilimumab and Nivolumab for the treatment of Melanoma

Hershey : Penn State Hershey Cancer Institue

A Phase 1/Phase 2 clinical study for patients with Metastatic Melanoma, Stage III Melanoma or Stage IV Melanoma

Hershey : Penn State University / Milton S. Hershey Medical Center SC-2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Philadelphia : Teva Investigational Site 10669

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center Updated

A clinical trial to evaluate treatments using MGA271 for patients

Philadelphia : Thomas Jefferson University

A clinical trial to evaluate treatments using Sunitinib and Valproic Acid for patients

Philadelphia :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Philadelphia : Thomas Jerfferson University Hospital SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Whole-Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery (SRS) for the treatment of Recurrent Melanoma, Stage IV Melanoma or Tumors Metastatic to Brain

Philadelphia : Kimmel Cancer Center at Thomas Jefferson Univ. Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Pittsburgh : Hillman Cancer Center

A clinical research study of Biospecimen banking for the treatment of Melanoma

Pittsburgh : University of Pittsburgh Medical Center- Hillman Cancer Center

A clinical research study of Craniotomy scheduled and Collection for non-craniotomy for the treatment of Melanoma or Brain Metastases

Pittsburgh : UPMC Hillman Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

Pittsburgh : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib 150 mg and Trametinib 2.0 mg for patients with Melanoma and Brain Metastases

Pittsburgh : Hillman Cancer Center

A clinical trial to evaluate treatments using High-dose Interferon alfa-2b and Vemurafenib for patients with Melanoma

Pittsburgh : Hillman Cancer Center

A Phase 1 clinical study for patients with Melanoma

Pittsburgh : University of Pittsburgh Medical Center SC-4

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pittsburgh : University of Pittsburgh Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Pittsburgh : University of Pittsburgh Cancer Institute SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pittsburgh : UPCI Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

South Carolina

Charleston : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Charleston : Research Site

Patients are needed to participate in a clinical research study of AMG 232, Trametinib and Dabrafenib

Greenville : Greenville Hospital System

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tennessee

Knoxville : University of Tennessee

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

Knoxville : University of Tennessee Medical Center

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Memphis : St. Jude Children'S Research Hospital Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Memphis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Memphis : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Memphis : University of Tennessee Cancer Institute Dept of Onc

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nashville : Sarah Cannon Research Institute Onc. Dept

A clinical research study for the treatment of Melanoma

Nashville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Nashville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Nashville : Sarah Cannon Research Institute Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Nashville : Sarah Cannon Research Institute Updated

A clinical trial to evaluate treatments using MGA271 for patients

Nashville : Sarah Cannon Research Institute

A Phase 1 clinical study for patients with Malignant Melanoma

Nashville : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Nashville : Sarah Cannon Research Institute SC - 2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

Nashville : Tennessee Oncology

Patients are needed to participate in a clinical research study evaluating glembatumumab vedotin for the treatment of Melanoma, Advanced Melanoma

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Nashville : Research Site

Patients are needed to participate in a clinical research study of AMG 232, Trametinib and Dabrafenib

Texas

Austin : Texas Oncology, P.A. SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dallas : Mary Crowley Medical Research Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Dallas : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Dallas : Mary Crowley Medical Center

A Phase 2 clinical study for patients with Melanoma

Dallas : University of Texas Southwestern Medical Center SC (5)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dallas : Baylor Health Care System/Sammons Cancer Center Oncology

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Dallas : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Dallas : Baylor Health Care System/Sammons Cancer Center Oncology

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Dallas : University of Texas Southwestern Medical Center SC-5

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Dallas : Dallas Surgical Group Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Houston : University of Texas MD Anderson Cancer Center

A clinical research study for the treatment of Melanoma

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Dabrafenib, Trametinib and Surgery for the treatment of Melanoma, Malignant Melanoma Stage IV or Metastatic Melanoma

Houston : The University Of Texas Md Anderson Cancer Center Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

Houston : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Houston : The University of Texas M.D. Anderson Cancer Center Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using investigational drug INGN 241 for patients with Malignant Melanoma or Neoplasm Metastasis

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using LY3009120 capsule for patients With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Houston : MD Anderson Cancer Center

A Phase 1 clinical study for patients with Metastatic Melanoma or Other Advanced Solid Tumors

Houston : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Melanoma

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Melanoma

Houston : University of Texas Health Science Center at Houston SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Houston :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ipilimumab to evaluate Melanoma

Houston : University of Texas Health Science Center Univ.TX Memorial Herman Cancer

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Houston : Call for Information (Investigational Site 0007)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Melanoma

Houston : Center for Clinical Studies Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Houston : Center for Clinical Studies Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Lubbock : Joe Arrington Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

San Antonio : South Texas Accelerated Research Therapeutics Updated

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

San Antonio :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Webster : Center for Clinical Studies Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Utah

Murray : Intermountain Medical Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Salt Lake City : Huntsman Cancer Institute

A clinical research study of CAVATAK (Coxsackievirus A21, CVA21) for the treatment of Malignant Melanoma

Salt Lake City : Primary Children'S Medical Center Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Salt Lake City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Salt Lake City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Salt Lake City : Clinical Site

A clinical trial to evaluate treatments using HF10 plus Ipilimumab for patients with Malignant Melanoma

Salt Lake City : Huntsman Cancer Institute

A Phase 2 clinical study for patients with Melanoma

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Salt Lake City : The Huntsman Cancer Institute, University of Utah Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Vermont

Colchester : Fletcher Allen Healthcare SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Virginia

Charlottesville : University of Virginia Health System

A Phase 2 clinical study for patients with Melanoma

Charlottesville : University of Virginia

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Charlottesville : University of Virginia Hospital Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Fairfax : Virginia Cancer Specialists, PC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fairfax : Inova Comprehensive Cancer and Research Institute Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Richmond : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Roanoke : Carillion Medical Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Washington

Everett : Providence Regional Medical Center Everett

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Everett : Providence Regional Cancer Partnership

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Seattle : University of Washington, Seattle Cancer Care Alliance

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma

Seattle : Swedish Cancer Institute Swedish Cancer Institute (SC)

A Phase 4 clinical study for patients using Pasireotide

Seattle : University of Washington Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Seattle : Call for Information (Investigational Site 0006)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Seattle : Seattle Cancer Care Alliance /University of Washington Cancer Consortium Updated

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Seattle : Virginia Mason Medical Center Updated

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Tacoma : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Wenatchee : Wenatchee Valley Medical Center Wenatchee Valley

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

E3612 - A Randomized Phase II Trial of Ipilimumab with or without Bevacizumab in Patients with Unresectable Stage III or Stage IV Melanoma

Wisconsin

Milwaukee : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Argentina

Buenos Aires : Instituto Médico Alexander Fleming

A clinical trial to evaluate treatments using CSF470 vaccine, BCG, Molgramostim and interferon alpha 2b for patients with Cutaneous Melanoma

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Buenos Aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Caba : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Capital Federal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Cordoba : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Rio Negro : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Rosario- Santa Fe : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tucuman : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Viedma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Australia

Adelaide : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Adelaide : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Adelaide : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bedford Park : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Box Hill : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Box Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Camperdown : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Canberra : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Corrimal : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Douglas : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

East Melbourne : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

East Melbourne : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

East Melbourne : Peter MacCallum Cancer Centre

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

East Melbourne : Research Site

Patients are needed to participate in a clinical research study of AMG 232, Trametinib and Dabrafenib

Frankston : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gateshead : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Gateshead : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Greenslopes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Greenslopes : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heidelberg : Austin Health, LICR Melbourne Austin Branch

A clinical research study of Bacillus Calmette-Guérin (BCG) vaccine and Ipilimumab for the treatment of Metastatic Melanoma

Heidelberg : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Heidelberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nedlands : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nedlands : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

North Ryde : Merck Sharp & Dohme

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

North Sydney : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

North Sydney : Melanoma Institute Australia

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

North Sydney : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

North Sydney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

North Sydney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

North Sydney : Research Site

Patients are needed to participate in a clinical research study of AMG 232, Trametinib and Dabrafenib

Prahran : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Southport : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tamworth : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tweed Heads : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tweeds Head : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wagga Wagga : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Westmead : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Westmead : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Woodville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Woolloongabba : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Woolloongabba : Princess Alexandra Hospital

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Woolloongabba : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Woolloongabba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Woolloongabba : Veracity Clinical Research Pty Ltd

Patients are needed to participate in a clinical research study of BLZ-100 to evaluate Skin Neoplasms

Woolloongabba : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Austria

Graz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Graz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Graz : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Graz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Innsbruck : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Innsbruck : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Linz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Linz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Salzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Salzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Salzburg : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Salzburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

St Poelten : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

St. Poelten : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Vienna : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wien : Medizinische Universität Wien

A clinical trial to evaluate treatments using IVAC MUTANOME, RBL001/RBL002 for patients with Melanoma

Wien : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Wien : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wien : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Belgium

Brasschaat : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Brugge : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Brugge : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Brussels : Cliniques universitaires Saint-Luc, Centre du Cancer

A Phase 1/Phase 2 clinical study for patients with Melanoma

Brussels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brussels : Institut Jules Bordet Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Brussels : Universitair Ziekenhuis Brussel Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Brussels : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bruxelles : Cliniques Universitaires St-Luc, Service d'oncologie médicale

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Jules Bordet Institute

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Bruxelles : Cliniques Universitaires Saint-Luc Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Edegem : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Edegem : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gent : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Hasselt : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Hasselt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kortrijk : Az Groeninge Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Kortrijk : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leuven : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Leuven : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leuven : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Leuven : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Leuven : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Liege : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Liege : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Liege : Chu Du Sart Tilman Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Liège : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wilrijk : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Wilrijk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brazil

Curitiba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ijui : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Passo Fundo : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Porto Alegre : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Rio de Janeiro : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

São Paulo - SP : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Canada

Calgary : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Edmonton : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Edmonton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Edmonton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Halifax : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Hamilton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Hamilton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hamilton : Juravinski Cancer Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

London : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

London : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Moncton : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montreal : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Montreal : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Montreal : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Montreal : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Montreal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Montreal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oshawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ottawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quebec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quebec : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Québec : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sainte-Foy : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Saskatoon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toronto : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Toronto : Princess Margaret Hospital

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Toronto : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Toronto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Toronto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Windsor : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

China

Beijing : Beijing Shijitan Hospital,CMU

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Shanghai : Fudan University Shanghai Cancer Center

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Colombia

Bogotá : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Czech Republic

Brno : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Brno : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brno : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hradec Kralove : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Olomouc : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Olomouc : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ostrava Poruba : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ostrava Poruba : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Praha : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Praha 10 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Praha 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Praha 10 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Praha 2 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Praha 2 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Praha 2 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Zlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Denmark

Århus C : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Copenhagen : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Copenhagen : Rigshospitalet

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Herlev : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Odense : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Finland

Jyvaskyla : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Oulu : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Tampere : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

France

Angers : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Angers : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Bayonne : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Besancon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Besançon : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Melanoma

Bordeaux : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : CHU Hôpital Saint André

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bordeaux Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bordeaux Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Boulogne : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Boulogne Billancourt : AP-HP Hôpital Ambroise Paré

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Boulogne Billancourt : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Boulogne Billancourt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Boulogne sur Mer : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Boulogne-Billancourt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Boulogne-Billancourt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brest : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Brest cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brest Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bron Cedex : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Caen : CHRU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Clermont Ferrand Cédex 1 : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dijon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Dijon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grenoble : CHU Michallon

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Grenoble : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Grenoble Cédex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grenoble Cédex 9 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Grenoble Cédex 9 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Le Kremlin Bicetre : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Le Mans : CH

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Le Mans Cedex 09 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Le Mans Cedex 09 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lille : CHRU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Lille : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Lille : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

LILLE Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

LILLE Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lille Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Limoges : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Limoges Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lyon : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Lyon Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lyon Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lyon sud : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Marseille : AP-HM

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Marseille : Hôpital Sainte Marguerite

Patients are needed to participate in a clinical research study evaluating masitinib and Dacarbazine for the treatment of Metastatic Melanoma

Marseille Cedex 05 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Marseille Cedex 5 : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Marseille cedex 5 : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Melanoma

Marseille Cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Marseille cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Montauban : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montpellier : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Montpellier cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mougins : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Nantes : Centre Hospitalier Universitaire de Nantes

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Nantes Cedex 1 : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Nantes Cedex 1 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Nice : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Nice : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nice Cedex 3 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nice Cedex 3 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nouvelle caledonie : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Orléans : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Paris : AP-HP Hôpital Saint Louis

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Paris : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Paris : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Paris : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Paris : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Paris : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Paris Cedex 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Paris Cedex 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Paris Cedex 10 : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Pierre Bénite : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Pierre-Benite Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pierre-Benite Cedex : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Pierre-Benite Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pierre-Bénite cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pierre-Bénite cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Poitiers : CHU Milétrie

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Quimper : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Reims : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Reims : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Reims : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Reims Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rennes : CHU Pontchaillou

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Rennes Cedex : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Melanoma

Rennes Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Rennes Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rouen Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Saint-Etienne : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Soissons cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Strasbourg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Strasbourg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Strasbourg Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toulouse : CHU Hôpital Larrey

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Toulouse cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Toulouse Cedex 9 : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Toulouse cedex 9 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tours : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Tours Cedex 9 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Vandoeuvre Les Nancy : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Villejuif Cedex : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Villejuif cedex : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Melanoma

Villejuif cedex : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Villejuif cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Villejuif cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Villejuif Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Germany

Aachen : Dept of Dermatology, University of Aachen

A Phase 3 clinical study for patients with Melanoma

Augsburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bayreuth : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Berlin : HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie

A clinical trial to evaluate treatments for patients with Colo-rectal Cancer, Stomach Cancer or Melanoma

Berlin : Dept of Dermatology, University of Berlin Charite

A Phase 3 clinical study for patients with Melanoma

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Berlin : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Berlin : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bochum : Dept of Dermatology, University of Bochum

A Phase 3 clinical study for patients with Melanoma

Bochum : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bochum : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Bochum : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bonn : Neurologische Universitaetsklinik Bonn

A clinical trial seeking patients for a research study for the treatment of Leptomeningeal Metastasis From Malignant Melanoma

Bonn : Medizinisches Zentrum Bonn Friedensplatz

A Phase 3 clinical study for patients with Melanoma

Bonn : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Buxtehude : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Buxtehude : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Chemnitz : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Chemnitz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Darmstadt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Darmstadt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dessau-Roblau : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dortmund : Klinikum Dortmund Ggmbh Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Dortmund : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dresden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dresden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Dresden : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Dresden : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Düsseldorf : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Erfurt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Erfurt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Erfurt : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Erfurt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erlangen : Uniklinik Erlangen Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Erlangen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erlanger : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Essen : Dept of Dermatology, University of Essen

A Phase 3 clinical study for patients with Melanoma

Essen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Essen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Essen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Essen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Essen : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Frankfurt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Frankfurt : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Frankfurt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Frankfurt / Main : Dept of Dermatology, University of Frankfurt

A Phase 3 clinical study for patients with Melanoma

Frankfurt/Oder : Dermatology, Klinikum Frankfurt/Oder

A Phase 3 clinical study for patients with Melanoma

Freiburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Freiburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Freiburg : University Medical Center Freiburg, Department of Dermatology

Patients are needed to participate in a clinical research study evaluating psycho-oncological intervention for the treatment of Malignant Melanoma

Freiburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Freiburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gera : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Gera : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Gera : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Gera : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Gera : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Gera : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Giessen : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Goettingen : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Hamburg : Uniklinik Hh Eppendorf Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Hamburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hamburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Hamburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Hamburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Hannover : Dept of Dermatology, University of Hannover

A Phase 3 clinical study for patients with Melanoma

Hannover : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Hannover : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hannover : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hannover : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Hannover : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heidelberg : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Heidelberg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Heidelberg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heidelburg : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Heilbronn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Heilbronn : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Homburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Homburg/Saar : Dept of Dermatology, Saarland University

A Phase 3 clinical study for patients with Melanoma

Jena : Dept of Dermatology, University of Jena

A Phase 3 clinical study for patients with Melanoma

Jena : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Jena : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kassel : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kassel : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Kiel : Dept of Dermatology, University of Schleswig-Holstein Campus Kiel

A Phase 3 clinical study for patients with Melanoma

Kiel : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Kiel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Kiel : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kiel : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Kiel : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Koblenz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Koeln : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Koeln : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Köln : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Köln : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Köln : University Medical Center Collogne, Department of Dermatology

Patients are needed to participate in a clinical research study evaluating psycho-oncological intervention for the treatment of Malignant Melanoma

Leipzig : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leipzig : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lübeck : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lübeck : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lübeck : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lüdenscheid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Ludwigshafen : Dermatology, Klinikum Ludwishafen

A Phase 3 clinical study for patients with Melanoma

Ludwigshafen : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Ludwigshafen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Luebeck : Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck

A Phase 3 clinical study for patients with Melanoma

Luebeck : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Magdeburg : Dept of Dermatology, Univeristy of Magdeburg

A Phase 3 clinical study for patients with Melanoma

Magdeburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Magdeburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Magdeburg : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Magdeburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Mainz : Hautklinik und Poliklinik Universitätsmedizin der Johannes-Gutenberg Universität Mainz

A clinical trial to evaluate treatments using IVAC MUTANOME, RBL001/RBL002 for patients with Melanoma

Mainz : Dept of Dermatology, University of Mainz

A Phase 3 clinical study for patients with Melanoma

Mainz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mainz : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mainz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Manheim : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Mannheim : Dept of Dermatology, University of Mannheim

A Phase 3 clinical study for patients with Melanoma

Mannheim : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Mannheim : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mannheim : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Marburg : Dept of Dermatology, University of Marburg

A Phase 3 clinical study for patients with Melanoma

Marburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Marburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Minden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Minden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Muenchen : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Muenchen : Dept of Dermatology, University of Muenchen

A Phase 3 clinical study for patients with Melanoma

Muenchen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Muenchen : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Muenchen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Muenchen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Muenster : Dept of Medical Oncology, Fachklinik Hornheide

A Phase 3 clinical study for patients with Melanoma

Muenster : Dept of Dermatology, University of Muenster

A Phase 3 clinical study for patients with Melanoma

Muenster : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Muenster : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Muenster : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

München : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Munster : Uniklinik Muenster Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Münster : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Nuernberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nuernberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nuernberg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Plauen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Quedlinburg : Dermatology, Klinikum Dorothea Christiane Erxleben

A Phase 3 clinical study for patients with Melanoma

Quedlinburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Quedlinburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quedlinburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Recklinghausen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Regensburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Regensburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Regensburg : University of Regensburg

Patients are needed to participate in a clinical research study evaluating dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus for the treatment of Advanced Melanoma

Regensburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Schwäbisch Hall : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Schwerin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Schwerin : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Schwerin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Stade : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Stade : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Traunstein : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Tubingen : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Tübingen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Tübingen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tübingen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tuebingen : University Hospital

A clinical research study of Arm 1: L19IL2 + Dacarbazine and Arm 2: Dacarbazine for the treatment of Metastatic Melanoma Stage IV

Tuebingen : Dept of Dermatology, University of Tuebingen

A Phase 3 clinical study for patients with Melanoma

Tuebingen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ulm : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Ulm : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ulm : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ulm : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wiesbaden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wuerzburg : Dept of Dermatology, University of Wuerzburg

A Phase 3 clinical study for patients with Melanoma

Wuerzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Würzburg : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Würzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Würzburg : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Würzburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Würzburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Greece

Athens : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Athens : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Athens : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Athens : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Athens : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Athens : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Thessaloniki : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Thessaloniki : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hungary

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Budapest : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Budapest : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Budapest : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Debrecen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kaposvar : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Szolnok : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Szolnok : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ireland

Dublin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Galway : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tullamore : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Israel

Beer Sheva : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Haifa : Rambam Health Care Campus

A clinical trial seeking patients for a research study for the treatment of Skin Lesions

Haifa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Haifa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Haifa : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Jerusalem : Oncology institute, Shaare Zedek Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Jerusalem : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Jerusalem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Jerusalem : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Jerusalem : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kiryat Bialik : Clalit Health Services

A clinical trial seeking patients for a research study for the treatment of Skin Lesions

Ramat Gan : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ramat Gan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ramat Gan : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ramat-Gan : Chaim Sheba Medical Center

Patients are needed to participate in a clinical research study of CM-24

Tel Aviv : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tel Hashomer : Ella Institute, Oncology institute, Sheba Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Tel Hashomer : Oncology Institute, Sheba Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Tel Hashomer : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Italy

Ancona : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Ancona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bari : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bari : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bergamo : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bergamo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bergamo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bologna : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Brescia : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Brescia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Candiolo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Candiolo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Genova : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Genova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Genova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lecco : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Meldola (FC) : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Milano : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Milano : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Milano : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Milano : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Monza : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Napoli : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Napoli : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Napoli : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Napoli : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Napoli : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Padova : Vanna Chiarion-Sileni, MD Updated

A clinical trial to evaluate treatments using Anti-B-RAF for patients with Metastatic Melanoma

Padova : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Padova : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Padova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Padova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Padova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Padova : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Palermo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pavia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pisa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pisa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ragusa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Roma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Rome : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Rozzano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of Arm 1: L19IL2 + Dacarbazine and Arm 2: Dacarbazine for the treatment of Metastatic Melanoma Stage IV

Siena : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Siena : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Terni : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Torino : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Udine : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Japan

Chuo-ku : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Chuo-ku : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fukuoka-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fukuoka-city : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hirakata-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Matsumoto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Matsumoto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Osaka : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Shizuoka : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tokyo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tsu : Mie University Hospital

A clinical trial to evaluate treatments using TBI-1201, Cyclophosphamide and Fludarabine for patients with Solid Tumors

Korea, Republic of

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mexico

Cancun : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Df : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Leon, Guanajato : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Mexico : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

México : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Netherlands

Amsterdam : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Amsterdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Amsterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Amsterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Amsterdam : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Breda : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Breda : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Eindhoven : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Enschede : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Groningen : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Groningen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Groningen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Heerlen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Leeuwarden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leiden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leiden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Leiden : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Maastricht : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Maastricht : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nijmegen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nijmegen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nijmegen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Rotterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rotterdam : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Zwolle : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Zwolle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

New Zealand

Auckland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wellington : Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Norway

Ålesund : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bergen : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Oslo : Oslo University Hospital, Radiumhospitalet

A clinical trial to evaluate treatments using Ipilimumab, UV1 vaccine and GM-CSF for patients with Malignant Melanoma, Metastatic Malignant Melanoma

Oslo : Oslo University Hospital Radiumhospitalet

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Oslo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Oslo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oslo : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Poland

Bydgoszcz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gdansk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Konin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Łódź : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Poznan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Poznan : WCO (Great Poland Cancer Centre)

Patients are needed to participate in a clinical research study of AGI-101H Vaccine to evaluate Melanoma

Warszawa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Warszawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Warszawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Warszawa : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Warszawa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Warszawa : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wrocław : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Portugal

Almada : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Almada : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lisboa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lisboa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lisboa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lisboa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Porto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Porto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Porto : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Russian Federation

Chelyabinsk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Moscow : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Moscow : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ryazan : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ryazan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ryazan : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Saint-Petersburg : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

St Petersburg : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

St Petersburg : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Volzhsky : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Singapore

Singapore : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Slovakia

Bratislava : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bratislava : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Poprad : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

South Africa

Bloemfontein : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Johannesburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pretoria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Spain

Alicante : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Badajoz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Badalona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Badalona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barakaldo : Hospital Universitario de Cruces

A clinical trial seeking patients for Mohs surgery research study

Barcelona : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Barcelona : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Barcelona : Hospital Vall d'Hebron

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Barcelona : H. Clinic de Barcelona

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Barcelona : Hospital del Mar

A clinical trial seeking patients for Mohs surgery research study

Barcelona : Hospital Quirón Teknon

A clinical trial seeking patients for Mohs surgery research study

Barcelona : Hospital Santa Creu i Sant Pau

A clinical trial seeking patients for Mohs surgery research study

Barcelona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Barcelona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Barcelona : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Barcelona : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cartagena (Murcia) : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Donostia : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

El Palmar : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Esplugues de Llobregat- Barcelona : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Granada : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Granada : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Guadalajara : Complejo Hospitalario Universitario de Guadalajara

A clinical trial seeking patients for Mohs surgery research study

Hospitalet de LLobregat : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Jerez de La Frontera : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

La Coruna : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Las Palmas de Gran Canaria : H. Insular de Canarias

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Las Palmas De Gran Canaria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Las Palmas De Gran Canaria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Las Palmas de Gran Canaria : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Las Palmas de Gran Canarias : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

León : Complejo Asistencial Universitario de León

A clinical trial seeking patients for Mohs surgery research study

L'Hospitalet del Llobregat : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Lleida : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Hospital 12 de Octubre

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Madrid : H. U. Gregorio Marañón

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Madrid : Hospital La Zarzuela

A clinical trial seeking patients for Mohs surgery research study

Madrid : Hospital Universitario Fundación de Alcorcón

A clinical trial seeking patients for Mohs surgery research study

Madrid : Hospital Gregorio Marañon

A clinical trial seeking patients for Mohs surgery research study

Madrid : Clínica Quirón

A clinical trial seeking patients for Mohs surgery research study

Madrid : Hospital de la Princesa

A clinical trial seeking patients for Mohs surgery research study

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Hospital De Madrid, Norte Sanchinarro Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Madrid : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Madrid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Madrid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Madrid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Majadahonda : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Malaga : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Malaga : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Málaga : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Málaga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Málaga : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oviedo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Palma : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Palma de Mallorca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pamplona : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Pamplona : Clínica Universidad de Navarra

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Pamplona : Clínica Universitaria de Navarra

A clinical trial seeking patients for Mohs surgery research study

Pamplona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pamplona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pamplona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pamplona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pamplona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pamplona : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

San Sabastian Gipuzkoa : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

San Sebastián : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Sebastián : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Santa Cruz de Tenerife : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Santa Cruz de Tenerife : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Santander : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Santiago de Compostela : H. Clínico de Santiago

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Santiago de Compostela : Complexo Hospitalario Universitario de Santiago

A clinical trial seeking patients for Mohs surgery research study

Santiago de Compostela; A Coruña : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sevilla : H.U. Virgen Macarena

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Sevilla : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Sevilla : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Sevilla : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Sevilla : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Sevilla : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Sevilla : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sta Cruz de Tenerife : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Terrassa : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toledo : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Valencia : H. General de Valencia

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Valencia : Instituto Valenciano de Oncología

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Valencia : Hospital Manises

A clinical trial seeking patients for Mohs surgery research study

Valencia : Instituto Valenciano de Oncología

A clinical trial seeking patients for Mohs surgery research study

Valencia : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Valencia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Valencia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Valencia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Valladolid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sweden

Gavle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Goteborg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Göteborg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Linköping : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lund : Lunds Universitetssjukhus

A Phase 2 clinical study for patients with Malignant Melanoma

Lund : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lund : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lund : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lund : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Stockholm : Södersjukhuset

A Phase 2 clinical study for patients with Malignant Melanoma

Stockholm : Karolinska Sjukhuset

A Phase 2 clinical study for patients with Malignant Melanoma

Stockholm : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Stockholm : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Umeå : Norrlands Universitetssjukhus

A Phase 2 clinical study for patients with Malignant Melanoma

Uppsala : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Uppsala : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Uppsala : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Switzerland

Aarau : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Baden : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Basel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Basel : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bern : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Chur : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Geneva 14 : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Genève : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lausanne : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Lausanne : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lugano : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Zuerich : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Zürich : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Zürich : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Zürich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Zürich : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Zürich : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Taiwan

Taichung : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Taipei : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Taipei : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Taoyuan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Turkey

Adana :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Adana :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Afyon :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Antalya : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bursa :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Denizli :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Diyarbakir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Edirne :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Erzurum :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Gaziantep :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Isparta :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Izmir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kayseri :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Konya :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Malatya :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Sıhhiye, ANKARA :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Trabzon :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

United Kingdom

Birmingham : Queen Elizabeth Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Birmingham : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Birmingham : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bristol : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Bristol :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Bristol : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bristol : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Broomfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Cambridge : Cambridge University Hospitals NHS Foundation Trust

A clinical trial to evaluate treatments using Pazopanib for patients

Cambridge : Addenbrooke's Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Cambridge :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Cambridge : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Cambridge : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cambridgeshire : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Cardiff : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Chelmsford :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Chelmsford : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Chelmsford, Essex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Exeter : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Exeter : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Glasgow : The Beatson Institute

A Phase 1 clinical study for patients with Malignant Melanoma

Glasgow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Glasgow : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Guildford : Department of Mecical Oncology, The Royal Surrey County Hospoital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Guildford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hull : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Leeds : St James University Hospital

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

Leeds : St James' Institute of Oncology

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Leeds : St James Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Leeds : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leeds : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leeds : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Leeds : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lincoln : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Institute of Cancer Research

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

London : Guy's Hospital

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

London :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

London : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : King's College London Guy's Hospital Campus

Patients are needed to participate in a clinical research study evaluating E7449 alone, E7449 plus TMZ and E7449 plus carboplatin and paclitaxel

London : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

London : Please contact the Merck KGaA Communication Center Updated

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

London : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

London : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Manchester : Christie Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Manchester :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Manchester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Manchester : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Manchester : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Merseyside : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Merseyside : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Newcastle : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Newcastle Upon Tyne :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Newcastle upon Tyne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Newcastle Upon Tyne : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Newcastle Upon Tyne and Wear : Newcastle Upon Tyne NHS Foundation Trust

Patients are needed to participate in a clinical research study evaluating E7449 alone, E7449 plus TMZ and E7449 plus carboplatin and paclitaxel

Northwood : Research Site Updated

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Northwood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Northwood : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Norwich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nottingham : Department of Clinical Oncology, City Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Oxford : NIHR Biomedical Research Centre

A Phase 1 clinical study for patients with Malignant Melanoma

Oxford :

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Oxford : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oxfordshire : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Plymouth : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Poole : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Preston : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Preston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Preston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Preston : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sheffield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Southampton : Department of Medical Oncology, Southampton General Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Southampton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Southend : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

St Helens. : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Staffordshire : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Surrey : University of Surrey

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

Surrey : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Surrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Surrey : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Sutton : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Sutton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Swansea : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Swansea : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Taunton, Somerset : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Truro : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Truro, Cornwall : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wirral : Clatterbridge Centre for Oncology NHS Foundation Trust

A clinical trial to evaluate treatments using Dacarbazine and Sunitinib for patients with Metastatic Uveal Melanoma

Wirral : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Wirral : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wolverhampton : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Yeovil, Somerset : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Venezuela

Caracas : Local Institution

Patients are needed to participate in a clinical research study evaluating Ipilimumab for the treatment of Melanoma